GSK/Theravance Seek to Expand Marketing of COPD Inhaler

The companies seek approval in the U.S. to expand their COPD inhaler Breo Ellipta (fluticasone furoate/vilanterol) for patients with asthma

Source: PharmaManufacturing.com - July 2, 2014 Category: Pharmaceuticals Source Type: news